Evaluating ChatGPT platform in delivering heart failure educational material: A comparison with the leading national cardiology institutes
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.ChatGPT answers on heart failure are harder to read and less actionable than traditional patient education materials. While AI chatbots show promise, further research is needed for reliable patient education resources.
Area Of Science
- Medical Informatics
- Artificial Intelligence in Healthcare
- Patient Education
Background
- Patient education is vital for heart failure management.
- Artificial intelligence (AI) chatbots are emerging as potential tools.
- ChatGPT is a widely recognized public chatbot.
Purpose Of The Study
- To evaluate the readability of ChatGPT responses for heart failure patient questions.
- To compare ChatGPT's educational material quality against existing resources.
Main Methods
- Comparative analysis of ChatGPT responses and materials from top US cardiology institutes.
- Readability assessment using validated calculators.
- Blind evaluation of readability and actionability via The Patient Education Materials Assessment Tool (PEMAT) by four heart failure specialists.
Main Results
- ChatGPT responses were longer and more difficult to read than existing materials.
- ChatGPT content was at an undergraduate and 9-10th grade reading level.
- ChatGPT achieved a competitive PEMAT readability score (75%) but had the lowest actionability score (66.7%).
Conclusions
- AI chatbots like ChatGPT have potential for patient education, with ongoing improvements.
- Current limitations necessitate further research to ensure AI chatbot integrity and reliability for patient use.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...